Operating Margin: Operating margin measurement of what proportion of a company's revenue is left over after paying for variable costs of production such as wages, raw materials, etc. Calculated as: Operating Income / Total Revenues
Xenetic Biosciences, Inc. (XBIO) had Operating Margin of -81.30% for the most recently reported fiscal quarter, ending 2025-12-31.
| Income Statement Financials | |
$0.77M |
|
$-0.58M |
|
-- |
|
$0.77M |
|
$1.39M |
|
$-0.62M |
|
$0.04M |
|
$-0.58M |
|
$-0.58M |
|
$-0.58M |
|
$-0.58M |
|
$-0.58M |
|
$-0.58M |
|
$-0.62M |
|
$-0.62M |
|
1.70M |
|
1.70M |
|
$-0.21 |
|
$-0.21 |
|
| Balance Sheet Financials | |
$8.05M |
|
-- |
|
$0.31M |
|
$8.36M |
|
$0.97M |
|
-- |
|
-- |
|
$0.97M |
|
$7.39M |
|
$7.40M |
|
$7.40M |
|
2.29M |
|
| Cash Flow Statement Financials | |
$-2.29M |
|
-- |
|
$4.00M |
|
$6.17M |
|
$7.88M |
|
$1.72M |
|
$0.06M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
8.32 |
|
-- |
|
-- |
|
-- |
|
-- |
|
100.00% |
|
|
Operating Margin |
-81.30% |
-81.30% |
|
-- |
|
-75.57% |
|
-75.57% |
|
$-2.29M |
|
-- |
|
-- |
|
-- |
|
0.09 |
|
-- |
|
-- |
|
-- |
|
-7.83% |
|
-7.83% |
|
-6.92% |
|
-7.83% |
|
$3.23 |
|
$-1.34 |
|
$-1.34 |
|